晨光生物(300138.SZ):新疆晨光擬終止向不特定合格投資者公開發行股票並在北交所申請並撤回申請材料
格隆匯4月8日丨晨光生物(300138.SZ)公佈,基於近期宏觀經濟及資本市場環境變化,綜合考慮子公司業務情況,經相關各方充分溝通、審慎分析後,晨光生物科技集團股份有限公司控股子公司——新疆晨光生物科技股份有限公司(簡稱“新疆晨光”)擬終止本次向不特定合格投資者公開發行股票並在北京證券交易所(簡稱“北交所”)上市事項,並向北交所申請撤回申請材料。
新疆晨光自籌劃本次公開發行股票並在北交所上市事項以來,積極推進相關工作,組織中介機構開展盡職調查等相關工作,並嚴格按照相關法律法規和規範性文件的要求履行了決策程序和信息披露的義務。基於目前資本市場環境變化等因素,經與相關各方充分溝通及審慎分析後,新疆晨光決定終止公開發行股票並在北交所上市並撤回相關上市申請文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.